[Application of arterial duct stent in ductus-dependent hypoplastic right heart syndrome]

G Luo1, A Liu1, K L Wang1

  • 1Heart Center,Qingdao Women and Children's Hospital, Qingdao 266034,China.

Insights

Arterial duct (AD) stenting is a safe and effective minimally invasive procedure for children with ductus-dependent hypoplastic right heart syndrome (HRHS). This technique offers a viable alternative to the traditional Blalock Taussig (B-T) shunt, reducing operation and hospitalization times.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Hypoplastic right heart syndrome (HRHS) with ductus-dependent pulmonary circulation presents significant management challenges.
  • Traditional palliative shunts like the Blalock Taussig (B-T) shunt carry known risks and longer recovery periods.

Purpose of the Study:

  • To evaluate the safety and efficacy of arterial duct (AD) stenting in neonates with ductus-dependent HRHS.
  • To compare AD stenting outcomes with those of B-T shunt procedures in a similar patient cohort.

Main Methods:

  • A retrospective review of seven children with HRHS who underwent AD stenting between January 2012 and January 2019.
  • Comparison of clinical outcomes, including operation time, intensive care unit (ICU) stay, hospitalization duration, and mortality, with nine HRHS patients who received a B-T shunt during the same period.

Main Results:

  • AD stenting group showed significantly shorter operation times (108±7 min vs. 160±49 min), ICU stays (3.4±1.0 days vs. 6.3±4.5 days), and total hospitalization (10.3±1.0 days vs. 26.3±1.0 days) compared to the B-T shunt group (all P<0.05).
  • Transcutaneous oxygen saturation significantly improved post-AD stenting (0.723±0.125 to 0.926±0.005, P<0.05).
  • No complications such as vascular injury, thrombus, or death were observed in the AD stenting group, while the B-T shunt group had a mortality rate of 33% (3/9).

Conclusions:

  • Arterial duct stenting is a feasible, effective, safe, and minimally invasive option for ductus-dependent HRHS.
  • AD stenting can serve as a valuable alternative to the B-T shunt, potentially improving patient outcomes and resource utilization.

Related Concept Videos